Preliminary results of a randomized study (radiotherapy versus radiotherapy plus weekly low-dose cisplatin) are reported. Fifty-four patients (43 evaluable) with stage IIIa-b non small cell lung cancer were randomized. Objective responses (CR+PR) were seen in 62% of the radiotherapy-treated group and in 63% of the group treated with radiotherapy plus cisplatin. No major toxicity was seen. Patient compliance for both treatments was satisfactory.
Get full access to this article
View all access options for this article.
References
1.
ChoiM.H.I., DoucetteJ.A.: Improved survival of patients with unresectable non small-cell bronchogenic carcinoma by an innovated high-dose en bloc radiotherapeutic approach.Cancer, 48: 101–109, 1981.
2.
HiltonG.: Present position relating to cancer of the lung. Results with radiotherapy alone.Thorax, 15: 17–18, 1960.
3.
KlasterskyJ.: Therapy with cisplatin and etoposide for non small cell lung cancer.Semin. Oncol., 13(suppl. 3): 104–114, 1986.
4.
MillerA.B., HoogstratenB., StaquetM., WimillerA.: Reporting results of cancer treatment.Cancer, 47: 207–214, 1981.
5.
MountainF.: A new international staging system for lung cancer.Chest, 89(suppl.): 225–233, 1986.
6.
SmartJ.: Can cancer of the lung be cured by radiation alone?JAMA, 195: 1034–1037, 1966.
7.
SoresiE., BorghiniU., ScocciaS., LeoniM., BotturriM., ClericiM.: Radiotherapy (RT) with cisplatin (CP) potentiation as neo-adjuvant approach in 39 inoperable NSCLC: a pilot study. Abst. 4917,. p. 1279. Proc. 14th Int. Cancer Congr., Budapest,. Aug. 21-27, 1986.
8.
SoresiE., BorghiniU., HarariS., BotturiM., LeoniM.: Cisplatinum and radiotherapy in the treatment of non small cell inoperable lung cancer.Tumori, (in press), 1987.
